Evidence map›Paper›PMID 24156898›Full record

ReviewThe Lancet. Infectious diseases2013

HIV-associated neurocognitive disorder.

David B Clifford, Beau M Ances

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in The Lancet. Infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 405 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
405citing papers in PubMed, 3 pooled it
18.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02571504 nacompletednot on this mapstarted 2015, after this paper: background citation

Brain Imaging to Understand HIV-associated Neurocognitive Disorder and Predict Response to Cognitive Training

TypeinterventionalSponsorMcGill UniversityRan2015 to 2017Enrolled81ConditionsHIV - Human Immunodeficiency Virus, Cognitive ImpairmentArmsPlasticity-based Adaptive Cognitive Remediation (PACR)
NCT02663934 naterminatednot on this mapstarted 2016, after this paper: background citation

Exercise Training to Improve Brain Health in Older HIV+ Individuals

TypeinterventionalSponsorWashington University School of MedicineRan2016 to 2020Enrolled75ConditionsHIVArmsExercise, Stretching and Social Interaction
3 · Its place in the literature

Who cites it

405 citing papers in PubMed, 3 syntheses or guidelines pooled it, 669 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Effects of Semaglutide on Cognitive Function in People With HIV: A Randomized, Controlled Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

345 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

David B CliffordDepartment of Neurology and Medicine, Washington University in St Louis, St Louis, MO, USA. Electronic address: cliffordd@wustl.edu.
Beau M Ances
Washington University in St. Louis · US

Funding

YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMESM01RR000036 · NCRR · WASHINGTON UNIVERSITY · PI NEWCOMER, JOHN W. · 1985 to 2007
$25.4M
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNITU01AI069495 · NIAID · WASHINGTON UNIVERSITY · PI CLIFFORD, DAVID B · 2007 to 2011
$7.7M
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNITUM1AI069495 · NIAID · WASHINGTON UNIVERSITY · PI CLIFFORD, DAVID B · 2012 to 2013
$2.9M
Frailty and Brain Integrity in Older HIV-infected IndividualsR01NR014449 · NINR · WASHINGTON UNIVERSITY · PI ANCES, BEAU M · 2013 to 2017
$2.4M
Washington University Network of Excellence in Neuroscience Clinical Trials SiteU10NS077384 · NINDS · WASHINGTON UNIVERSITY · PI CLIFFORD, DAVID B · 2011 to 2017
$1.9M
NEUROIMAGING AND NEUROBEHAVIORAL BASIS OF RISKY DECISION-MAKING IN ADOLESCENTSR01NR012907 · NINR · WASHINGTON UNIVERSITY · PI ANCES, BEAU M · 2011 to 2015
$1.9M
THE EFFECTS OF AGE AND HIGHLY ACTIVE ANTIRETROVIRAL THERAPY ON BRAIN FUNCTIONR01NR012657 · NINR · WASHINGTON UNIVERSITY · PI ANCES, BEAU M · 2010 to 2014
$1.9M
Calibrated BOLD fMRI of HIV Associated Neurocognitive Impairment (HNCI)K23MH081786 · NIMH · WASHINGTON UNIVERSITY · PI ANCES, BEAU M · 2007 to 2012
$820k
NCRR NIH HHS M01 RR000036NIAID NIH HHS AI069495NIAID NIH HHS U01 AI069495NIAID NIH HHS UM1 AI069495NIMH NIH HHS K23 MH081786NIMH NIH HHS K23MH081786NINDS NIH HHS NS077384NINDS NIH HHS U10 NS077384NINR NIH HHS R01 NR012657NINR NIH HHS R01 NR012907NINR NIH HHS R01NR012907NINR NIH HHS R01 NR014449NINR NIH HHS R01NR014449PHS HHS 22005PHS HHS R01NRO012657
6 · The paper itself

Abstract

Neurological involvement in HIV is often associated with cognitive impairment. Although severe and progressive neurocognitive impairment has become rare in HIV clinics in the era of potent antiretroviral therapy, most patients with HIV worldwide have poor outcomes on formal neurocognitive tests. In this Review, we describe the manifestations of HIV-associated neurocognitive disorder in the era of effective HIV therapy, outline diagnosis and treatment recommendations, and explore the research questions that remain. Although comorbid disorders, such as hepatitis C infection or epilepsy, might cause some impairment, their prevalence is insufficient to explain the frequency with which it is encountered. HIV disease markers, such as viral load and CD4 cell counts, are not strongly associated with ongoing impairment on treatment, whereas cardiovascular disease markers and inflammatory markers are. New cerebrospinal fluid and neuroimaging biomarkers are needed to detect and follow impairment. Ongoing research efforts to optimise HIV therapy within the CNS, and potentially to intervene in downstream mechanisms of neurotoxicity, remain important avenues for future investigation. Ultimately, the full control of virus in the brain is a necessary step in the goal of HIV eradication.

Indexed as

HIVAIDS Dementia ComplexCognition DisordersHumans

Identifiers

PMID24156898
PMCPMC4108270
OpenAlexW2170457399

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.